124 related articles for article (PubMed ID: 37787935)
1. Tumor-Targeted Delivery of IL-2 by Fusing with a pH Low Insertion Peptide for Antitumor Immunotherapy.
Chu T; Cao B; Wang P; Li B; Ren J; Nie G; Wei J; Li S
Bioconjug Chem; 2023 Oct; 34(10):1894-1901. PubMed ID: 37787935
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules Using a pH-Low Insertion Peptide.
Svoronos AA; Bahal R; Pereira MC; Barrera FN; Deacon JC; Bosenberg M; DiMaio D; Glazer PM; Engelman DM
Mol Pharm; 2020 Feb; 17(2):461-471. PubMed ID: 31855437
[TBL] [Abstract][Full Text] [Related]
3. pHLIP(Var7)-P1AP suppresses tumor cell proliferation in MDA-MB-231 triple-negative breast cancer by targeting protease activated receptor 1.
Yu M; Chen Y; Wang Z; Ding X
Breast Cancer Res Treat; 2020 Apr; 180(2):379-384. PubMed ID: 32034579
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Evaluation of Radioiodine-Labeled pH (Low) Insertion Peptide Variant 7-Like Peptide as a Noninvasive Tumor Microenvironment Imaging Agent in a Mouse MDA-MB-231 Triple-Negative Breast Cancer Model.
Wu F; Chen Y; Li D; Wang Z; Yu M
Mol Imaging Biol; 2022 Aug; 24(4):570-579. PubMed ID: 35006491
[TBL] [Abstract][Full Text] [Related]
5. Ku80-Targeted pH-Sensitive Peptide-PNA Conjugates Are Tumor Selective and Sensitize Cancer Cells to Ionizing Radiation.
Kaplan AR; Pham H; Liu Y; Oyaghire S; Bahal R; Engelman DM; Glazer PM
Mol Cancer Res; 2020 Jun; 18(6):873-882. PubMed ID: 32098827
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.
Burns KE; Robinson MK; Thévenin D
Mol Pharm; 2015 Apr; 12(4):1250-8. PubMed ID: 25741818
[TBL] [Abstract][Full Text] [Related]
7. pH-responsive pHLIP (pH low insertion peptide) nanoclusters of superparamagnetic iron oxide nanoparticles as a tumor-selective MRI contrast agent.
Wei Y; Liao R; Mahmood AA; Xu H; Zhou Q
Acta Biomater; 2017 Jun; 55():194-203. PubMed ID: 28363789
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic modeling reveals parameters that govern tumor targeting and delivery by a pH-Low Insertion Peptide (pHLIP).
Svoronos AA; Engelman DM
Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443162
[TBL] [Abstract][Full Text] [Related]
9. Fusion cytokine IL-2-GMCSF enhances anticancer immune responses through promoting cell-cell interactions.
Wen Q; Xiong W; He J; Zhang S; Du X; Liu S; Wang J; Zhou M; Ma L
J Transl Med; 2016 Feb; 14():41. PubMed ID: 26850448
[TBL] [Abstract][Full Text] [Related]
10. pH low insertion peptide mediated cell division cycle-associated protein 1 -siRNA transportation for prostatic cancer therapy targeted to the tumor microenvironment.
Zhao Z; Li C; Song B; Sun J; Fu X; Yang F; Wang H; Yan B
Biochem Biophys Res Commun; 2018 Sep; 503(3):1761-1767. PubMed ID: 30131247
[TBL] [Abstract][Full Text] [Related]
11. Tumor Acidic Microenvironment Targeted Drug Delivery Based on pHLIP-Modified Mesoporous Organosilica Nanoparticles.
Zhang Y; Dang M; Tian Y; Zhu Y; Liu W; Tian W; Su Y; Ni Q; Xu C; Lu N; Tao J; Li Y; Zhao S; Zhao Y; Yang Z; Sun L; Teng Z; Lu G
ACS Appl Mater Interfaces; 2017 Sep; 9(36):30543-30552. PubMed ID: 28809111
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis therapy antibody interleukin-2 fusion protein elicits prolonged and targeted antitumor effects in vivo.
Ye L; Fan J; Shi X; Tao Q; Ye D; Xian Z; Zeng X; Li Y; Feng M; Ju D
Appl Microbiol Biotechnol; 2014 May; 98(9):4053-61. PubMed ID: 24276620
[TBL] [Abstract][Full Text] [Related]
13.
Zhang Y; Ji W; He L; Chen Y; Ding X; Sun Y; Hu S; Yang H; Huang W; Zhang Y; Liu F; Xia L
Theranostics; 2018; 8(6):1690-1705. PubMed ID: 29556350
[No Abstract] [Full Text] [Related]
14. In Vivo Distribution and Therapeutic Efficacy of Radioiodine-Labeled pH-Low Insertion Peptide Variant 3 in a Mouse Model of Breast Cancer.
Zhang M; Xi Y; Chen H; Hai W; Li B
Mol Imaging; 2022; 2022():7456365. PubMed ID: 35903249
[TBL] [Abstract][Full Text] [Related]
15. pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation.
An M; Wijesinghe D; Andreev OA; Reshetnyak YK; Engelman DM
Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20246-50. PubMed ID: 21048084
[TBL] [Abstract][Full Text] [Related]
16. A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells.
Song Q; Chuan X; Chen B; He B; Zhang H; Dai W; Wang X; Zhang Q
Drug Deliv; 2016 Jun; 23(5):1734-46. PubMed ID: 25853477
[TBL] [Abstract][Full Text] [Related]
17. Metabonomic Investigation of Biological Effects of a New Vessel Target Protein tTF-pHLIP in a Mouse Model.
Ding L; Zhang C; Liu Z; Huang Q; Zhang Y; Li S; Nie G; Tang H; Wang Y
J Proteome Res; 2020 Jan; 19(1):238-247. PubMed ID: 31603327
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effect of pHLIP-amanitin.
Moshnikova A; Moshnikova V; Andreev OA; Reshetnyak YK
Biochemistry; 2013 Feb; 52(7):1171-8. PubMed ID: 23360641
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]